Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Hearts-Science is a forward-thinking organization focused on the research, development, and application of cutting-edge technologies and scientific breakthroughs to address critical challenges in cardiovascular health. We are committed to improving patient outcomes by pioneering novel diagnostic tools, therapeutic interventions, and preventative strategies. Our work integrates deep scientific expertise in cardiology with innovative approaches in data science, biomedical engineering, and clinical research to create impactful solutions for heart disease, a leading cause of mortality worldwide. We aim to foster a collaborative environment that brings together leading researchers, clinicians, and industry partners to accelerate the translation of scientific discoveries into tangible benefits for patients and healthcare systems.
The headquarters serves as the central hub for research and development, strategic planning, corporate administration, and business development activities.
State-of-the-art laboratory facilities, collaborative workspaces designed to foster innovation, and proximity to leading academic institutions and medical centers.
The work culture at the Hearts-Science HQ is characterized by a fast-paced, intellectually stimulating environment. Emphasis is placed on scientific rigor, teamwork, open communication, and a shared passion for making a difference in cardiovascular medicine. Employees often engage in cross-functional projects and continuous learning.
Its location in a major biotech hub provides Hearts-Science with unparalleled access to a rich ecosystem of research talent, potential collaborators, investors, and cutting-edge technologies, crucial for its mission.
Hearts-Science supports its mission through a strategically positioned headquarters in a leading US biotech hub, complemented by regional offices in key markets like California and the UK. These locations facilitate global research collaborations, clinical trial management across diverse populations, engagement with international regulatory bodies, and tailored market access strategies to bring cardiovascular innovations to patients worldwide.
1 Innovation Drive, Suite 200
Cambridge
MA
USA
Address: 456 BioPharma Ave, Suite 100, San Diego, CA 92121, USA
To manage and expand clinical research activities, engage with Key Opinion Leaders (KOLs) on the West Coast, and explore strategic alliances within the Pacific biotech cluster.
Address: 789 HealthTech Row, London, W1G 0JR, UK
To facilitate European market entry, manage regulatory submissions, and build relationships with European healthcare providers and research institutions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Hearts & Science' leadership includes:
Hearts & Science has been backed by several prominent investors over the years, including:
Over the past year, Hearts-Science has strategically strengthened its leadership team with key appointments to drive its next phase of growth and innovation, particularly in clinical development and financial strategy. There were no major executive departures during this period.
Discover the tools Hearts & Science uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Hearts-Science typically utilizes a standard professional email format, most commonly combining the first initial and last name, or first name and last name separated by a dot, followed by the company domain.
[first_initial][last]@hearts-science.com OR [first].[last]@hearts-science.com
Format
evance@hearts-science.com or eleanor.vance@hearts-science.com
Example
85%
Success rate
BioSpace • February 15, 2024
Hearts-Science announced today the initiation of its Phase II clinical trial for HS-001, a novel therapeutic agent for treating chronic heart failure. The study aims to evaluate the efficacy and safety of HS-001 in a larger patient population....more
FierceBiotech • September 5, 2023
Hearts-Science has successfully closed a $50 million Series B financing round. The funding will be used to advance its lead drug candidate through clinical trials and expand its research platform for discovering new cardiovascular therapies....more
Endpoints News • May 20, 2023
Researchers from Hearts-Science presented compelling preclinical data for their innovative approach to treating cardiac arrhythmias at the Annual Cardiology Innovation Summit. The data highlighted significant potential for their HS-002 compound....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Hearts & Science, are just a search away.